Invention Grant
- Patent Title: Selective estrogen receptor modulator for the treatment of osteoarthritis
- Patent Title (中): 选择性雌激素受体调节剂治疗骨关节炎
-
Application No.: US13062272Application Date: 2009-09-03
-
Publication No.: US08476300B2Publication Date: 2013-07-02
- Inventor: Jeffrey Alan Dodge , Timothy Ivo Richardson , Christian Alexander Clarke , Scott Alan Jones , Ronald Jay Hinklin , Conrad Wilson Hummel , George Sal Lewis
- Applicant: Jeffrey Alan Dodge , Timothy Ivo Richardson , Christian Alexander Clarke , Scott Alan Jones , Ronald Jay Hinklin , Conrad Wilson Hummel , George Sal Lewis
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent MaCharri Vorndran-Jones
- International Application: PCT/US2009/055805 WO 20090903
- International Announcement: WO2010/036497 WO 20100401
- Main IPC: A61K31/4453
- IPC: A61K31/4453 ; C07D211/06
Abstract:
The present invention is directed to a compound of the formula (A): or a pharmaceutically acceptable salt thereof; and also to compounds of formula (I): or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20110166182A1 Selective Estrogen Receptor Modulator for the Treatment of Osteoarthritis Public/Granted day:2011-07-07
Information query
IPC分类:
